Duty cuts on cancer drugs to ease financial burden, especially for poorer patients
The article analyzes the financial burden of cancer treatment in India, noting that it is three times higher than for other ailments. Medicines constitute the largest component of expenditure, especially in public hospitals in rural areas. While private hospitals charge more, the relative financial strain is higher in the government sector, particularly for the poor. The Budget's proposal for full exemption of basic customs duty on 17 cancer-related drugs is a crucial intervention. Data shows that the cost multiplier for cancer treatment in public hospitals increased from 4x in 2014 to 5x in 2017-18, highlighting the deepening financial strain on patients.
Key Points
- Cancer treatment is significantly more expensive than other ailments, with medicines being the largest cost component.
- Despite lower absolute costs, the relative financial burden of cancer treatment is higher for patients in public hospitals, especially in rural areas.
- The Union Budget's full exemption of basic customs duty on 17 cancer-related drugs is a critical step to reduce patient costs.
- The cost multiplier for cancer treatment in public hospitals has increased, indicating a growing financial strain on poorer patients.
Exam Facts
- Cancer treatment costs are three times higher than average ailment hospitalisation.
- The 2017-18 National Sample Survey (NSS) on health showed average cost for cancer patients was ₹61,000 per visit.
- In 2017-18, a cancer stay in a public hospital cost about five times a standard admission (₹22,520 vs ₹4,452).
- The Budget proposed full exemption of basic customs duty on 17 cancer-related drugs.
- Medicines account for 40-50% of total expense in public hospitals.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.